Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Doptelet
Pharma
Sobi boosts hematology sales with growth across key brands
The Swedish drugmaker reported 13% sales growth in its hematology portfolio, which includes brands such as Doptelet and Vonjo.
Zoey Becker
Jul 16, 2024 1:27pm
In $1.7B buy, Sobi acquires CTI and myelofibrosis drug Vonjo
May 10, 2023 11:25am
Sobi acquires Dova in $915M hematology franchise play
Sep 30, 2019 12:03pm
Tiny Dova and its Doptelet drug take on Novartis blockbuster
Jun 28, 2019 10:25am
Salix inks deal with Dova, 3rd recent deal to boost portfolio
Oct 5, 2018 11:03am
